| Phase 4 |
| NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With… |
Breast Cancer |
Recruiting |
2026-07-02 |
| Phase 2 |
| NCT05901519 |
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic… |
Hepatocellular Carcinoma |
Recruiting |
2026-10-15 |
| NCT03099356 |
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory… |
Metastatic Thyroid Cancer |
Recruiting |
2026-07-31 |
| NCT07121595 |
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the… |
Oral Cavity Squamous Cell Carcinoma |
Recruiting |
2026-07-31 |
| NCT06784336 |
Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in… |
Allogeneic Stem Cell Transplant |
Recruiting |
2026-07-21 |
| NCT06356155 |
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer |
Urothelial Carcinoma |
Recruiting |
2026-07-16 |
| NCT07094685 |
Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck… |
Advanced Head and Neck Squamous Cell Carcinoma |
Recruiting |
2026-06-26 |
| NCT07158021 |
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal… |
Anatomic Stage I Breast Cancer AJCC v8 |
Recruiting |
2026-06-23 |
| NCT05956041 |
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell… |
Cutaneous T Cell Lymphoma |
Recruiting |
2026-05-05 |
| NCT07443943 |
A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in… |
Anatomic Stage 0 Breast Cancer AJCC v8 |
Recruiting |
2026-04-24 |
| NCT05894083 |
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at… |
Oropharyngeal Cancer |
Recruiting |
2026-02-02 |
| NCT04858256 |
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms |
T-Cell Neoplasm |
Recruiting |
2026-01-29 |
| NCT05038332 |
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known… |
Prostate Cancer |
Recruiting |
2026-01-16 |
| NCT06580054 |
Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or… |
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck |
Active, Not Recruiting |
2026-07-29 |
| NCT04140162 |
Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment… |
Multiple Myeloma |
Active, Not Recruiting |
2026-07-28 |
| NCT04748042 |
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy… |
Prostate Cancer |
Active, Not Recruiting |
2026-07-13 |
| NCT06234748 |
Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer |
Oropharynx Cancer |
Active, Not Recruiting |
2026-05-18 |
| NCT05988918 |
Multicenter Trial of ESK981 in Patients With Select Solid Tumors |
Pancreatic Adenocarcinoma |
Active, Not Recruiting |
2026-05-14 |
| NCT04848337 |
Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer |
Prostate Cancer Metastatic |
Active, Not Recruiting |
2026-05-11 |
| NCT04574856 |
Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in… |
Glioblastoma |
Active, Not Recruiting |
2026-03-25 |
| NCT03787680 |
Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) |
Prostate Cancer |
Active, Not Recruiting |
2026-03-23 |
| Phase 1/2 |
| NCT06866262 |
Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic… |
Locally Advanced Clear Cell Renal Cell Carcinoma |
Recruiting |
2026-07-31 |
| NCT06616155 |
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant… |
Castration-Resistant Prostate Carcinoma |
Recruiting |
2026-05-05 |
| NCT03781986 |
APG-115 in Salivary Gland Cancer Trial |
Malignant Salivary Gland Cancer |
Active, Not Recruiting |
2026-07-13 |
| NCT04194554 |
A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP… |
Prostate Cancer |
Active, Not Recruiting |
2026-05-01 |